MEDICINE DETAILS
Padcev
Active ingredient: Enfortumab Vedotin Ejfv
Neutral reference profile for an independent medicine-access consultancy enquiry about Padcev (Enfortumab Vedotin Ejfv). No medicine is offered for sale.
NEXT STEP
Choose the strength and pack
✓ If you are unsure, choose “I do not know”.
These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.
ABOUT THIS MEDICINE
What is Padcev used for?
Padcev (enfortumab vedotin-ejfv) is a Nectin-4-directed antibody and microtubule inhibitor conjugate indicated to treat adults with cancer of the urinary system (urothelial cancer). This type of cancer includes cancer of the bladder, renal pelvis, ureter, or urethra that has spread (metastasized) to nearby tissues or to other areas of the body or cannot be removed by surgery (unresectable).
It is used in patients who are ineligible for cisplatin-containing chemotherapy and have previously received one or more prior lines of therapy.
It is available in vial form containing 20 mg or 30 mg enfortumab vedotin-ejfv.
This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.
RECORDED PRODUCT PROFILE
Padcev identity, dosage form and pack information.
The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.
Recorded strength and pack options
Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.
-
20 mg · 1 vial Catalogue organisation: Astellas Pharma GmbH
-
30 mg · 1 vial Catalogue organisation: Astellas Pharma GmbH
OFFICIAL SOURCES
Check the Padcev record at an official source.
Search for “Padcev” or “Enfortumab Vedotin Ejfv”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.
OFFICIAL EXTERNAL SOURCE
European Medicines Agency (EMA)
Search medicines evaluated by EMA by brand name or active substance. EMA also links to national registers for nationally authorised products.
↗ OFFICIAL EXTERNAL SOURCE Drugs@FDASearch FDA-approved human drug records by brand name or active ingredient, including current labelling where available.
↗SERVICE BOUNDARY
Information checking and independent enquiry support for Padcev.
OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.
Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.
CLEAR ANSWERS
Frequently asked questions about Padcev
01What is Padcev?＋
This directory record associates the brand name Padcev with the active ingredient Enfortumab Vedotin Ejfv. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.
02Which Padcev strengths and packs are recorded?＋
The catalogue currently shows: 20 mg · 1 vial; 30 mg · 1 vial. Check the complete strength, dosage form and pack description against the prescription and medicine box.
03Who manufactures Padcev?＋
Catalogue records currently name: Astellas Pharma GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.
04Do the listed options confirm stock or access?＋
No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.
05What affects a possible estimated medicine cost for Padcev?＋
A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Padcev, payment request, stock guarantee or binding offer.
06Can I buy Padcev from this website?＋
No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.